IGF2BP1 and hepatocellular carcinoma: However, in HCC development, HCG11 was demonstrated to be highly expressed and unregulated in the activity of IGF2BP1, by which it modulated the downstream signaling of IGF2BP1, including p21/capase-3 and MAPK, and subsequently affected the growth and metastasis of HCC.